Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Key target for Foot-and-Mouth drug revealed

A complete picture of Foot-and-Mouth Disease's key replication enzyme could lead to the development of new drugs to control the disease without recourse to vaccination or slaughter, scientists report today.

21 Mar 2005

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

Schering-Plough today reported that the U.S. Food and Drug Administration (FDA) has granted approval for Temodar (temozolomide) Capsules for use in combination with radiotherapy for the treatment of adult patients with newly diagnosed glioblastoma multiforme (GBM), a form of malignant brain cancer.

16 Mar 2005

How are choices for healing performances related to religious change and gender?

Who has made Mama Raja ill? Was it witchcraft, evil spirits, malaria or God's punishment? Dutch researcher Ien Courtens discovered that in the interior of the Bird's Head of West Papua, the presumed cause of the illness determines the choice of treatment.

16 Mar 2005

Anthrax scare in Pentagon false alarm

Two of the Pentagon mailrooms have been subjected to Anthrax tests in response to what appears to have been false alarms. The tests, which have been negative, were done a day after initial testing indicated the deadly spores might be present in some areas, prompting nearly 900 workers to take antibiotics as a precaution; it closed three mail facilities - two that serve the Pentagon and one in Washington that handles mail on its way to the military.

15 Mar 2005

Vaccine for whooping cough in teens

The U.S. Food and Drug Administration (FDA) is recommending the development of a vaccine to prevent the occurrence of pertussis (Whooping Cough) in adolescents.

15 Mar 2005

Pelvic floor exercises versus ‘holding on’ in treatment of incontinence

Pelvic floor muscle exercises could feel the squeeze when they go up against toilet techniques in a new study to find the best way to treat incontinence.

15 Mar 2005

Drug combo gives lung cancer patients longer life

Preliminary results from a large randomized clinical trial, sponsored by the National Cancer Institute (NCI), by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., have shown that patients with previously untreated advanced non-squamous non-small cell lung cancer who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005

Mountain dwellers live longer

People who live in mountain areas live longer than those living in lowland areas, according to research from Greece, which has the lowest death rate from heart disease of any developed country.

15 Mar 2005

Innovative computer modeling technique predicts how protein molecule behavior in response to environmental conditions

In a development that could have great significance for efforts to understand how the basic molecular machinery of life works, researchers at the University of Texas Medical Branch at Galveston (UTMB) have successfully applied an innovative computer modeling technique to predicting how protein molecules will behave in response to different environmental conditions.

15 Mar 2005

ID Biomedical pursues accelerated approval of influenza vaccine

ID Biomedical Corporation announced today that it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's injectable influenza vaccine is eligible for accelerated approval and priority review mechanisms, allowing possible licensure of the vaccine in time to manufacture product for the 2006/07 season.

15 Mar 2005

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers

Preliminary results from a large, randomized clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those patients who received bevacizumab (AvastinTM) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005

Disparities in health care are pervasive in America

Disparities in health care are pervasive in America. These disparities adversely impact the cardiovascular health of Americans, especially African Americans, Hispanics, poor and uneducated people, according to a report in a special disparities themed issue of Circulation: Journal of the American Heart Association.

15 Mar 2005

Novel Australian anti-cancer therapy has begun safety testing in human subjects

An international medical conference here heard that an Australian developed anti-cancer therapy based on the use of a common cold virus to control cancer cell growth has begun safety testing in human subjects.

15 Mar 2005

Bird flu could kill 2 million Brits

A UK expert is warning that the bird flu pandemic is imminent and inevitable and two million Britons could die.

14 Mar 2005

Cough medicine may cause seizures

Canadian consumers are being advised by Health Canada not to use specific brands of a generic cough syrup that could possibly result in seizures for children under three years of age.

14 Mar 2005

Ten more cases of human bird flu in Viet Nam

Full information is desperately needed to assess the risks of a pandemic that in a worst-case scenario could claim tens of millions of lives worldwide says the United Nations health agency.

14 Mar 2005

New H5N1 avian influenza vaccine

Merial today announced the introduction of a new inactivated vaccine, GALLIMUNE Flu H5N9, developed and shown to be effective specifically for use against the highly pathogenic avian influenza virus H5N1 that has caused devastating economic losses in the poultry industry in Asia, and which has been linked to the deaths of over 29 humans.

14 Mar 2005